The Acute Hospital Care at Home (AHCAH) waiver was extended through September 30, 2030 by the Consolidated Appropriations Act of 2026, signed in February 2026. The law also decoupled the program’s statutory authority from government-funding deadlines, ending the cycle of short-term extensions. Health systems now have a stable five-year horizon to launch or scale hospital-at-home programs, and the operational planning window has reopened.
Is the hospital at home waiver still active in 2026?
Yes. The waiver is active and extended through September 30, 2030.
The Consolidated Appropriations Act of 2026, signed in February 2026, made two things happen at once. It extended the AHCAH waiver (first created in November 2020 during the COVID-19 public health emergency) through September 30, 2030. And it decoupled the program’s statutory authority from government-funding deadlines, so future shutdowns won’t put the program in limbo. (Source: Moving Health Home; American Medical Association.)
Continuity matters here because the program had a real scare. The waiver lapsed briefly during the 43-day government shutdown in late 2025, and several health systems paused or wound down operations during the gap. The 2030 extension restored continuity and removed the structural fragility that caused the lapse in the first place. (Source: Healthcare Dive; HealthLeaders.)
As of early 2026, 366 programs across 139 health systems in 37 states are approved to provide acute hospital care at home. (Source: AMA.) That number is a starting point. With the 2030 horizon in place, both expansion at existing programs and new program launches are back on the planning table.
What did the 2030 extension actually change?
Three things, in descending order of operational impact.
- First, the time horizon. Before February 2026, the waiver carried short-term extensions tied to government-funding cycles. Capital planning, hiring, technology investment, and partnership decisions all ran into the same wall: “does the program even exist in eighteen months?” The five-year horizon to September 30, 2030 changes how every one of those decisions gets made.
- Second, the decoupling. The 2026 law separated the program’s statutory authority from funding-bill deadlines. In practical terms: a future shutdown or continuing-resolution fight doesn’t put the waiver back at risk on the same schedule. The program now operates on its own statutory clock. (Source: AMA.)
- Third, the signal. CMS, hospital boards, and clinical leaders read the long extension as a federal commitment to the model. Investments that were on hold can move. Vendors that paused product roadmaps can resume them. Health systems that wanted to wait for a 2032 picture before committing have one.
What didn’t change: the underlying operational requirements. CMS approval, eligibility criteria, monitoring requirements, billing standards, quality reporting. Those continue as before. The 2026 law moved the runway, not the rules.
Why does long-term certainty matter for health systems?
Hospital at home isn’t a quick install.
Standing up a program requires investment in clinical staffing, remote monitoring technology, mobile care delivery, pharmacy and supply chain, and a 24/7 care coordination layer. Total setup costs vary by scale, but $1M to $5M+ is a reasonable planning band for the first year, with annual operating cost running well above that.
That kind of investment doesn’t pencil against a 12-month reimbursement horizon. CFOs reading the cash flow rationally said no, or said “pilot, but don’t scale,” through most of 2024 and 2025. The 2026 extension gives boards and finance committees enough horizon to approve the model at full scale.
Three planning consequences follow.
- Capital approvals move. Programs that had a paper case but stalled at finance can pull the case back off the shelf. The five-year reimbursement horizon makes the ROI math work.
- Hiring restarts. Hospital-at-home clinical leads, mobile RN cohorts, pharmacy coordinators, technology integration staff. Health systems can post these roles confidently because the program will still exist when the new hires reach steady state.
- Partnership decisions resolve. Technology vendors, mobile clinical providers, pharmacy partners, care coordination platforms. Vendor selection processes that had been waiting on certainty can run to conclusion.
For systems already operating, the extension reframes the conversation from “can we keep this running?” to “how do we scale it?”
What should a health system do now to start or scale a program?
A practical sequence.
If you don’t have a program yet:
- Decide the strategic case in the next 90 days. Hospital at home is not a marginal initiative; it touches capacity, length of stay, readmissions, patient satisfaction, and the system’s relationship with Medicare. Make it a board-level decision, not a service-line side bet.
- Identify the patient cohort. Most programs start with three to five conditions (cellulitis, COPD exacerbation, heart failure, pneumonia, UTI requiring IV antibiotics) and expand from there. Use your own admission data to size the eligible population.
- Get CMS approval underway. The application process is straightforward but takes time. Start now, not after the rest of the program is built.
- Stand up the seven core capabilities: physician leadership, mobile clinical teams, continuous monitoring, rapid response, pharmacy and supply chain, 24/7 patient access and coordination, and reimbursement infrastructure. The 24/7 access and coordination layer is often the part that gets underestimated.
Pilot inside three to six months. Scale on what you learn.
If you already have a program:
- Reopen the scale plan. The 2030 horizon supports the multi-year expansion most operating programs paused in 2024-2025.
- Look at the cohort. Most operating programs are running well below their addressable patient population. Often the limit is coordination capacity, monitoring capacity, or referral pipeline from inpatient teams, not clinical capability.
- Audit the coordination layer. As patient census grows, the 24/7 access function tends to be the first bottleneck. Programs that bolt this on with informal coverage hit a ceiling fast. Programs that treat it as core infrastructure scale further with the same clinical team.
- Document outcomes. The 2024 CMS study showed lower mortality and fewer post-discharge costs than brick-and-mortar inpatient care across the program. (Source: Healthcare Dive.) Programs that publish their own outcomes, the way the Marshfield program does, gain credibility, referrals, and political support inside the system. Marshfield reports 90%+ patient satisfaction, a 44% reduction in readmission rate, and a 35% drop in average length of stay. (Source: AMA. Outcomes attributed to the named program.)
Where does care coordination fit?
It’s the backbone.
A hospitalized patient on a floor has the team next to them. A hospitalized patient at home has a scattered team that has to function as one unit. Coordination is what makes that work.
Specifically: a 24/7 live-person access layer for patients, families, and the care team. Clinically trained coordinators who can answer the phone at 3 a.m., assess what’s happening, dispatch the right response, and document the encounter. AI underneath handling intake, routing, demand prediction, transcription, and the routine volume. No IVR. No automation wall.
That’s the function the SENA Access Command Center performs for hospital-at-home programs. The same model that cuts front-office costs by up to 50% in medical groups holds a hospital-at-home program together for a health system, with SOC 2 Type 2 attestation underneath and a 9.7 customer satisfaction score in front.
Programs that scale through 2030 will be the ones that treat coordination as core infrastructure, not as a phone tree someone bolts on at the end. The 2030 extension gives you the planning runway. Use it to build the model that actually scales.
For a broader walk-through of what hospital at home is and how it differs from home health, see What is hospital at home? A guide for health systems.
Frequently asked questions
When does the hospital at home waiver expire?
The current authorization expires September 30, 2030. The Consolidated Appropriations Act of 2026 extended the AHCAH waiver to that date and decoupled the program’s statutory authority from government-funding deadlines.
Is hospital at home still covered by Medicare in 2026?
Yes. Approved hospitals continue to bill eligible hospital-at-home admissions at the same DRG-based rate as a brick-and-mortar inpatient stay through the AHCAH waiver, now extended through September 30, 2030.
What was the Consolidated Appropriations Act of 2026?
The 2026 federal funding law, signed in February 2026, which among other provisions extended the AHCAH waiver through September 30, 2030 and decoupled its statutory authority from government-funding deadlines. (Source: AMA; Moving Health Home.)
How do hospitals get approved?
Hospitals apply to CMS for AHCAH waiver approval, demonstrating clinical capability, staffing, monitoring infrastructure, rapid response, and quality reporting capacity. As of early 2026, 366 programs across 139 health systems in 37 states have been approved.
Related: What is hospital at home? · How care coordination reduces hospital readmissions · Learn more about the Clinical Command Center.
